You are here

Ojemda

Ipsen builds again, licensing Day One glioma drug

Pharmaphorum

Thu, 07/25/24 - 11:10 am

Day One Biopharmaceuticals

Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor

BioSpace

Wed, 04/24/24 - 08:46 am

Day One Biopharmaceuticals

pediatric low-grade glioma